Average Insider

Where insiders trade, we follow

$BLCO
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
Healthcare
Sector
Medical - Instruments & Supplies
Industry
Brenton L. Saunders
CEO
13500
Employees
$16.25
Current Price
$6.10B
Market Cap
52W Low$10.45
Current$16.2568.5% above low, 31.5% below high
52W High$18.91

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys77$1,074,368.1261,464All Buys
Sells00--
2 monthsBuys99$1,224,096.1269,864All Buys
Sells00--
3 monthsBuys99$1,224,096.1269,864All Buys
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Mar 6, 2026
SAUNDERS BRENT L
Director
Purchase14,700$17.14$251,958.00View Details
Mar 6, 2026
Eldessouky Sam
EVP and CFO
Purchase4,000$17.13$68,520.00View Details
Mar 6, 2026
Bailey A Robert D
EVP & Chief Legal Officer
Purchase14,600$17.15$250,331.60View Details
Mar 3, 2026
Ross Thomas W. Sr.
Director
Purchase4,500$17.68$79,555.50View Details
Feb 27, 2026
VON ESCHENBACH ANDREW C.
Director
Purchase4,364$18.30$79,883.02View Details
Mar 2, 2026
Alfonso Eduardo
Director
Purchase4,300$17.90$76,970.00View Details
Feb 23, 2026
COLLIS STEVEN H
Director
Purchase15,000$17.81$267,150.00View Details
Feb 20, 2026
ROBERTSON RUSSEL C
Director
Purchase4,400$17.90$78,760.00View Details
Feb 19, 2026
Ling Karen
Director
Purchase4,000$17.74$70,968.00View Details
2 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Feb 18, 2026
EPS
Estimated$0.35
ActualN/A
Revenue
Estimated$1.39B
ActualN/A

Related Activity

Cross-company insider connections and cluster buy signals
Version: v26.3.23